D3RMIS is an ideal pre-market stage start-up with a revolutionary, patent-pending wound dressing product (Product X) that addresses the unmet need for new and innovative solutions for the treatment of patients with trauma, burn and chronic wounds. Our dressing is uniquely formulated from safe and biocompatible biomaterials for rapid and optimal wound regeneration with features engineered to satisfy wound care needs such as high absorbency, anti-adherent, painless, and conducive to epidermal cell infiltration and proliferation. This exclusive formulation presents numerous benefits compared to traditional wound dressings, including ease of application and the promotion of scarless healing of donor site wounds with potential for reharvest. In addition, our dressing is also cost-effective and can be easily stored with a long shelf life, making it a practical solution for healthcare facilities to enhance the standard of wound care, while simultaneously reducing treatment cost and relieving
Co-Founder & CEO
Co-Founder and Chief Business Development Officer
Co-Founder & Chief Technology Officer
Co-Founder & Chief Scientific Officer
Intellectual Property